Formycon Gets Date For Aflibercept Filing In US

US FDA Offers June 2024 Action Date For Coherus-Partnered FYB203 Eylea Biosimilar

 
• By David Wallace
  
Eyes US flag
Formycon is eyeing a June 2024 FDA action date for FYB203 • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products